Cargando…

Exceptional in vivo catabolism of neurodegeneration-related aggregates

Neurodegenerative diseases are linked to a systemic enzyme resistance of toxic aggregated molecules and their pathological consequences. This paper presents a unique phenomenon that Philodina acuticornis, a bdelloid rotifer, is able to catabolize different types of neurotoxic peptide and protein agg...

Descripción completa

Detalles Bibliográficos
Autores principales: Datki, Zsolt, Olah, Zita, Hortobagyi, Tibor, Macsai, Lilla, Zsuga, Katalin, Fulop, Livia, Bozso, Zsolt, Galik, Bence, Acs, Eva, Foldi, Angela, Szarvas, Amanda, Kalman, Janos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789616/
https://www.ncbi.nlm.nih.gov/pubmed/29378654
http://dx.doi.org/10.1186/s40478-018-0507-3
_version_ 1783296316480159744
author Datki, Zsolt
Olah, Zita
Hortobagyi, Tibor
Macsai, Lilla
Zsuga, Katalin
Fulop, Livia
Bozso, Zsolt
Galik, Bence
Acs, Eva
Foldi, Angela
Szarvas, Amanda
Kalman, Janos
author_facet Datki, Zsolt
Olah, Zita
Hortobagyi, Tibor
Macsai, Lilla
Zsuga, Katalin
Fulop, Livia
Bozso, Zsolt
Galik, Bence
Acs, Eva
Foldi, Angela
Szarvas, Amanda
Kalman, Janos
author_sort Datki, Zsolt
collection PubMed
description Neurodegenerative diseases are linked to a systemic enzyme resistance of toxic aggregated molecules and their pathological consequences. This paper presents a unique phenomenon that Philodina acuticornis, a bdelloid rotifer, is able to catabolize different types of neurotoxic peptide and protein aggregates (such as beta-amyloids /Aβ/, alpha-synuclein, and prion) without suffering any damage. P. acuticornis is capable of using these aggregates as an exclusive energy source (i.e., as ‘food’, identified in the digestive system and body) in a hermetically isolated microdrop environment, increasing their survival. As regards Aβ1–42, five other bdelloid rotifer species were also found to be able to perform this phenomenon. Based on our experiments, the Aβ1–42-treated bdelloid rotifers demonstrate significantly increased survival (e.g. mean lifespan = 51 ± 2.71 days) compared to their untreated controls (e.g. mean lifespan = 14 ± 2.29 days), with similar improvements in a variety of phenotypic characteristics. To our knowledge, no other animal species have so far been reported to have a similar capability. For all other microscopic species tested, including monogonant rotifers and non-rotifers, the treatment with Aβ1–42 aggregates proved to be either toxic or simply ineffective. This paper describes and proves the existence of an unprecedented in vivo catabolic capability of neurotoxic aggregates by bdelloid rotifers, with special focus on P. acuticornis. Our results may provide the basis for a new preclinical perspective on therapeutic research in human neurodegenerative diseases.
format Online
Article
Text
id pubmed-5789616
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57896162018-02-08 Exceptional in vivo catabolism of neurodegeneration-related aggregates Datki, Zsolt Olah, Zita Hortobagyi, Tibor Macsai, Lilla Zsuga, Katalin Fulop, Livia Bozso, Zsolt Galik, Bence Acs, Eva Foldi, Angela Szarvas, Amanda Kalman, Janos Acta Neuropathol Commun Research Neurodegenerative diseases are linked to a systemic enzyme resistance of toxic aggregated molecules and their pathological consequences. This paper presents a unique phenomenon that Philodina acuticornis, a bdelloid rotifer, is able to catabolize different types of neurotoxic peptide and protein aggregates (such as beta-amyloids /Aβ/, alpha-synuclein, and prion) without suffering any damage. P. acuticornis is capable of using these aggregates as an exclusive energy source (i.e., as ‘food’, identified in the digestive system and body) in a hermetically isolated microdrop environment, increasing their survival. As regards Aβ1–42, five other bdelloid rotifer species were also found to be able to perform this phenomenon. Based on our experiments, the Aβ1–42-treated bdelloid rotifers demonstrate significantly increased survival (e.g. mean lifespan = 51 ± 2.71 days) compared to their untreated controls (e.g. mean lifespan = 14 ± 2.29 days), with similar improvements in a variety of phenotypic characteristics. To our knowledge, no other animal species have so far been reported to have a similar capability. For all other microscopic species tested, including monogonant rotifers and non-rotifers, the treatment with Aβ1–42 aggregates proved to be either toxic or simply ineffective. This paper describes and proves the existence of an unprecedented in vivo catabolic capability of neurotoxic aggregates by bdelloid rotifers, with special focus on P. acuticornis. Our results may provide the basis for a new preclinical perspective on therapeutic research in human neurodegenerative diseases. BioMed Central 2018-01-29 /pmc/articles/PMC5789616/ /pubmed/29378654 http://dx.doi.org/10.1186/s40478-018-0507-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Datki, Zsolt
Olah, Zita
Hortobagyi, Tibor
Macsai, Lilla
Zsuga, Katalin
Fulop, Livia
Bozso, Zsolt
Galik, Bence
Acs, Eva
Foldi, Angela
Szarvas, Amanda
Kalman, Janos
Exceptional in vivo catabolism of neurodegeneration-related aggregates
title Exceptional in vivo catabolism of neurodegeneration-related aggregates
title_full Exceptional in vivo catabolism of neurodegeneration-related aggregates
title_fullStr Exceptional in vivo catabolism of neurodegeneration-related aggregates
title_full_unstemmed Exceptional in vivo catabolism of neurodegeneration-related aggregates
title_short Exceptional in vivo catabolism of neurodegeneration-related aggregates
title_sort exceptional in vivo catabolism of neurodegeneration-related aggregates
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789616/
https://www.ncbi.nlm.nih.gov/pubmed/29378654
http://dx.doi.org/10.1186/s40478-018-0507-3
work_keys_str_mv AT datkizsolt exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT olahzita exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT hortobagyitibor exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT macsaililla exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT zsugakatalin exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT fuloplivia exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT bozsozsolt exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT galikbence exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT acseva exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT foldiangela exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT szarvasamanda exceptionalinvivocatabolismofneurodegenerationrelatedaggregates
AT kalmanjanos exceptionalinvivocatabolismofneurodegenerationrelatedaggregates